News

Published on 29 Jun 2022 on Zacks via Yahoo Finance

3 Reasons to Retain Catalent (CTLT) Stock in Your Portfolio


Article preview image

Catalent, Inc. CTLT is well-poised for growth in the coming quarters, backed by its robust facility-expansion activities over the past few months. A robust third-quarter fiscal 2022 performance, along with a slew of strategic deals over the past few months, is expected to contribute further. Catalent’s operation in a competitive landscape and regulatory requirements pose threats.

Over the past year, this Zacks Rank #3 (Hold) stock has lost 2.2% compared with a 30.8% fall of the industry and 11.6% decline of the S&P 500.

The renowned global provider of advanced delivery technologies has a market capitalization of $19.01 billion. Catalent projects 17.3% growth for the next five years and expects to maintain its strong performance. It has delivered an earnings surprise of 9.2% for the past four quarters, on average.

NASDAQ.OMCL price evolution
NYSE.CTLT price evolution
NASDAQ.MASI price evolution
NYSE.AMN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?

EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. populatio...

Zacks · via Yahoo Finance 28 Nov 2024

Masimo (MASI): A Promising Medical Stock with Growth Potential

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this...

Insider Monkey · via Yahoo Finance 1 Nov 2024

Is Masimo Corporation (NASDAQ:MASI) The Top Stock With Improving Technical...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this pie...

Insider Monkey · via Yahoo Finance 11 Oct 2024

Masimo Corporation (MASI) Faces a Fierce Battle Against Activist Hedge Fund...

We recently compiled a list of the Shake-Up Alert: 40 Companies Facing Activist Pressure. In this...

Insider Monkey · via Yahoo Finance 24 Aug 2024

Is Now An Opportune Moment To Examine Masimo Corporation (NASDAQ:MASI)?

Masimo Corporation (NASDAQ:MASI), might not be a large cap stock, but it saw a decent share price...

Simply Wall St. · via Yahoo Finance 23 Jun 2024

Masimo Corporation (NASDAQ:MASI) Q1 2024 Earnings Call Transcript

Masimo Corporation (NASDAQ:MASI) Q1 2024 Earnings Call Transcript May 7, 2024 Masimo Corporation ...

Insider Monkey via Yahoo Finance 5 May 2024

Reasons Why You Should Retain Masimo (MASI) Stock for Now

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its researc...

Zacks via Yahoo Finance 19 Apr 2024

Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?

Masimo MASI is witnessing strong momentum, with its shares having rallied 17.9% year to date comp...

Zacks via Yahoo Finance 17 Apr 2024

Stifel upgrades Masimo to buy, sees room for share price appreciation (NASDAQ:MASI)

Stifel upgraded Masimo (MASI) to buy, citing improvement in the company's healthcare business, gr...

Seeking Alpha 16 Apr 2024

Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 24% Undervaluation?

Key Insights Masimo's estimated fair value is US$181 based on 2 Stage Free Cash Flow to EquityCur...

Simply Wall St. via Yahoo Finance 14 Apr 2024